See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eid
Natural Disasters
Social Media
Artificial Intelligence
Tariffs
Donald Trump
Stock Markets
Baseball
European Union
Soccer
Vladimir Putin
Tesla
Published • loading... • Updated

European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11

Summary by Hastings Tribune
SHANGHAI, China & JERSEY CITY, N.J.--(BUSINESS WIRE)--Mar 28, 2025-

3 Articles

All
Left
Center
2
Right
Hastings TribuneHastings Tribune
Reposted by
Post RegisterPost Register
Center

European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11

SHANGHAI, China & JERSEY CITY, N.J.--(BUSINESS WIRE)--Mar 28, 2025-

Read Full Article
economx.hueconomx.hu

Richter has taken a big step, the new registration is near

The European Medicines Agency has accepted Richter's new application for registration. Richter announced on Thursday that the European Medicines Agency (EMA) has accepted its application for registration ... ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Hastings Tribune broke the news in on Friday, March 28, 2025.
Sources are mostly out of (0)

Similar News Topics

Shanghai, China

Shanghai, China

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal